| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zosano Pharma Corp | VP, Clinical Dev & Med Affairs | Common Stock | 56,331 | 31 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZSAN | Zosano Pharma Corp | 31 Mar 2022 | 1 | -$841 | 4 | VP, Clinical Dev & Med Affairs | 01 Apr 2022, 21:08 |
| ZSAN | Zosano Pharma Corp | 15 Oct 2021 | 2 | $0 | 4 | VP, Clinical Dev & Med Affairs | 19 Oct 2021, 21:36 |
| ZSAN | Zosano Pharma Corp | 04 Jun 2021 | 1 | -$1,375 | 4 | VP, Clinical Dev & Med Affairs | 07 Jun 2021, 18:42 |